Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial.
about
Evaluation of B-type natriuretic peptide for validation of a heart failure register in primary care.Early recognition of heart failure in patients with diabetes type 2 in primary care. A prospective diagnostic efficiency study. (UHFO-DM2).Natriuretic Peptide testing in primary careDiagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trialBNP but Not s-cTnln is associated with cardioembolic aetiology and predicts short and long term prognosis after cerebrovascular eventsThe survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study.The REFER (REFer for EchocaRdiogram) protocol: a prospective validation of a clinical decision rule, NT-proBNP, or their combination, in the diagnosis of heart failure in primary care. Rationale and design.Peak oxygen uptake in relation to total heart volume discriminates heart failure patients from healthy volunteers and athletesMeta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction.Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community.Natriuretic peptides in the diagnosis and management of heart failureRecent advances in natriuretic peptide researchCorin in clinical laboratory diagnosticsAssessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis.The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.Diagnosis and assessment of the heart failure patient: the cornerstone of effective management.Brain natriuretic peptide in the contemporary management of congestive heart failure.N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure.Acutely decompensated congestive heart failure: new therapies for an old problem.CNP Signal Peptide in Patients with Cardiovascular Disease.Recent Patient Characteristics and Medications at Admission and Discharge in Hospitalized Patients With Heart Failure.Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.The ability of heart failure specialists to accurately predict NT-proBNP levels based on clinical assessment and a previous NT-proBNP measurement.Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure.Natriuretic peptide testing in primary care patients.Primary care REFerral for EchocaRdiogram (REFER) in heart failure: a diagnostic accuracy study.Biomarkers in heart failure--better than history or echocardiography?Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care.B-type natriuretic peptides: looking to the future.Updating the role of natriuretic peptide levels in cardiovascular disease.Development and initial validation of a simple clinical decision tool to predict the presence of heart failure in primary care: the MICE (Male, Infarction, Crepitations, Edema) rule.Leptin in heart failure.Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer.European Society of Cardiology-Acute Cardiovascular Care Association Position paper on acute heart failure: A call for interdisciplinary care.Validation of heart failure diagnosis registered in primary care records in two primary care centres in Barcelona (Spain) and factors related. A cross-sectional study.Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction.The patient with dyspnea. Rational diagnostic evaluation.Effect of sialylated O-glycans in pro-brain natriuretic peptide stability.
P2860
Q33292472-8330C761-9F2F-477B-B13A-A5942613D10DQ33520099-4E666D07-E004-4617-BC3E-7842DA0F7719Q33572286-783AE6BF-F8FD-4094-9FC8-1753EABEFFC2Q33854806-ABEA44EA-473B-4A43-A3C3-C86CF5B85CAAQ33967122-97EAF965-AE06-43D8-88F2-6D567EF609C1Q33984662-63B06370-35B4-4425-A208-AB00ECABD38BQ34203867-8CC71A06-3958-462F-9F17-714C099501C3Q34461484-C8B0E0CF-AD4B-417E-8598-02AD6A0D689FQ34499726-15E4E5AD-53B5-42D5-8A8E-0D70D02483F7Q34753074-0184A0B3-EE6B-4A94-8A0A-3861E97D366CQ34980239-EDDA33EE-9F90-4AD3-8EC5-F4E8B2FCD107Q35015563-C24BCA87-8683-471D-9A84-F7AE5AFF706DQ35459776-73EDEBB7-0F54-4436-8879-0F7E620A0ED3Q35634038-638405DE-F32F-475C-BD01-DBC935A9025BQ35678102-276DBAF4-F430-4BD3-A1A9-F84830EA99EAQ35717608-FFFAA989-6745-4EE2-B1D5-B071D408BE04Q36046578-55AAE3CC-2585-401C-8045-9E88CE0AD259Q36050481-FA405FD7-6427-4C34-A427-4D1904273D45Q36124913-B0E4BC3B-089B-4AEC-B2E4-21B0F0B4AE2EQ36266039-0379301F-FAF8-405B-84D8-85881E33C539Q36351139-80131A78-0EBA-409F-A9EA-FE712449C94AQ36429719-1A143F9E-5C9C-4DDF-99EA-2365C72B21E9Q36716456-9B0A1841-C332-4119-9CC8-3C028076E167Q36922698-22BE5A95-F1AE-48EA-97BF-31D4DB82B28EQ36944131-68441444-9C14-44A2-9160-027974C6B442Q37092258-D28BCF10-B149-40CC-A516-367EB87EF15FQ37291305-AA5C3934-72A7-45B2-A04A-213CE83B11BCQ37641033-AB8EDC09-4BBF-4E1D-9A72-5E5D90C4EF32Q37660171-3E0F29F7-FBD1-4051-AFA8-806031268D48Q37762320-1852CA18-B025-4F42-A445-0AE7A882F07EQ37801667-351831CB-1381-47B0-AA2F-42C88DED8A6BQ37959158-A9E3E414-1FA4-4155-9D79-CD20E71E18B3Q38020022-10956599-CE42-4496-9CA3-4F00E4AE8FA7Q38093250-1DE3455C-0D5D-45ED-A3BE-DC8AFBDD3ED6Q38518602-C668B10F-BA0C-46A6-871B-37E67D45CB89Q38540467-0DD2E3BD-D63A-4848-9F98-2AC79EC8A66BQ38855301-AC6373FD-1180-4B53-A2B5-377A69A5C4ADQ39127729-7D69438E-C4EB-45FA-8652-BA9992EC6117Q39212072-CBBE8D76-8402-417A-824E-14D467B31176Q39721683-00222E4F-F3AF-4456-9C0D-050B4C2F36DA
P2860
Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Plasma amino-terminal pro-brai ...... randomized, controlled trial.
@ast
Plasma amino-terminal pro-brai ...... randomized, controlled trial.
@en
type
label
Plasma amino-terminal pro-brai ...... randomized, controlled trial.
@ast
Plasma amino-terminal pro-brai ...... randomized, controlled trial.
@en
prefLabel
Plasma amino-terminal pro-brai ...... randomized, controlled trial.
@ast
Plasma amino-terminal pro-brai ...... randomized, controlled trial.
@en
P2093
P1476
Plasma amino-terminal pro-brai ...... randomized, controlled trial.
@en
P2093
Gary Gordon
Greg D Gamble
Helen J Walsh
Helen Oxenham
Mark Richards
Norman Sharpe
Robert N Doughty
Susan P Wright
Tim Yandle
P304
P356
10.1016/J.JACC.2003.05.011
P407
P577
2003-11-01T00:00:00Z